What You Should Know:
– Today, Inato unveiled new AI capabilities to enhance and accelerate site selection. Sponsors can now use Inato’s platform to create and execute data-driven site selection scenarios based on real-time interest and…
Continue Reading
What You Should Know:
– Inato, the leading platform for clinical trial access and inclusivity, today unveiled new capabilities to help research sites efficiently pre-screen patients for trial opportunities.
– The company’s latest advancement integrates a…
Continue Reading
Inato, the leading technology platform enabling access to inclusive clinical trials, today announced the close of $20 million in Series A2 funding from existing and new investors. The fundraise includes return and lead investor…
Continue Reading
In todays fast-paced world, it is easy to miss out on important information, especially if you are trying to keep up with a lot of different sources. That is where the daily digest comes in – it is a tool that compiles all the posts created on the previous day, providing you with a convenient summary of everything that happened so you can stay informed, educated, and engaged with the Digital Health world around you.
Continue Reading
Almost three-quarters of all clinical trials are run by the same 5% of academic sites, according to Inato CEO Kourosh Davarpanah.
“This lack of patient access causes trial delays and costs to skyrocket, ultimately constraining…
In todays fast-paced world, it is easy to miss out on important information, especially if you are trying to keep up with a lot of different sources. That is where the daily digest comes in – it is a tool that compiles all the posts created on the previous day, providing you with a convenient summary of everything that happened so you can stay informed, educated, and engaged with the Digital Health world around you.
Continue Reading
What You Should Know:– Inato, a technology platform that connects pharma companies (trial sponsors) with community-based trial sites raises $20M in new funding (A2) led by Cathay Innovation with participation from existing investor Obvious…
Continue Reading
Clinical trial startup Inato scooped up $20 million in a Series A2 funding round led by Cathay Innovation.The raise included returning investor Obvious Ventures and new participants La Maison and Top Harvest Capital. The…
Continue Reading
